Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90
Published November 2, 2022 · Recall initiated: October 5, 2022
Summary
FDA records drug Class II recall D-0021-2023, published November 2, 2022 and initiated October 5, 2022. Recalling firm: Aurobindo Pharma USA Inc.; Status: Completed; Reported quantity: 9504 bottles; Lot: Lots QE2021005-A and QE2021010-A, exp 01/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Nationwide
- UPC
- 0365862161901
- Lot
- Lots QE2021005-A and QE2021010-A, exp 01/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by:November 2, 2022
- FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons ofNovember 2, 2022
- FDAAtenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by:November 2, 2022
- FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons ofNovember 2, 2022
- FDAPyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only,November 2, 2022
- FDAAmla Alcohol-Free Extract, 2 oz. glass bottle, UPC 041979376093 and Amla Alcohol-Free Extract, 4 oz. glassNovember 2, 2022
Questions about this recall
Was Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90 recalled?
Yes. FDA published recall D-0021-2023 on November 2, 2022. Reported hazard: CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE. UPC: 0365862161901.